The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

About 20 years ago, the U.S. Food and Drug Administration approved the first GLP-1 medication for Type 2 diabetes. Today, the landscape has shifted, as the agency has approved various ...

The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...

Dosage adjustments for GLP-1s are a normal part of treatment, helping the body adapt and minimize side effects while optimizing benefits for weight loss. Doctors may increase your GLP-1 dose if weight ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn't available. Here are 9 reputable places ...

KUALA LUMPUR, Feb 10 — Often referred to as a ‘miracle drug’, glucagon-like peptide-1 (GLP-1) ...

New Super Bowl commercials in 2026 featuring GLP-1 drugs and tennis icon Serena Williams may help normalize their use, and ...

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

According to doctors, making a misstep is easier than you may think.

GLP-1 is a peptide hormone generated from proglucagon that is secreted after meals by enteroendocrine L-cells in the distal jejunum, ileum, and colon. GLP-1 is also produced by pancreatic α-cells and ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...